Retatrutide 10mg Research-grade Retatrutide (LY-3437943), a synthetic triple GLP-1/GIP/glucagon receptor agonist peptide studied for advanced metabolic research
Semaglutide is a GLP-1 receptor agonist, meaning it mimics the natural GLP-1 hormone that affects appetite and digestion
Lipotropic injections: Cost, dosage, and risks (Lifestyle importance)
Frequently asked questions Can I switch from semaglutide to tirzepatide mid-escalation
Reported benefits (per available research): Studied for its ability to produce sustained, dose-dependent increases in growth hormone and IGF-1 secretion in a Phase 1 human trial in healthy adults, published by Teichman et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 10.Wanders R.J.A., Ruiter J.P.N., IJlst L., Waterham H.R., Houten S.M